FindTrial
Sign In

adverse drug reactions and quality of life with anti-hiv treatment

A study to evaluate adverse drug reactions and quality of life in HIV/AIDS patients at ART center of Rajindra hospital, Patiala.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017398
Enrollment
100
Registered
2019-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV positive

Interventions

None listed

Sponsors

Dr Ruchika Irene Dillu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of HIV on ART, being treated on OPD basis. 2. Patient willing to participate in the study and give written informed consent after having been explained about the nature of the study

Exclusion criteria

Exclusion criteria: 1. Patient having known hypersensitivity to any ART drug. 2. Patient not willing to participate in the study after having been explained about the nature of the study. 3. Seriously ill patients 4. CD4 count below 200µl/mm3 i.e., Stage 3 and stage 4 patients

Design outcomes

Primary

MeasureTime frame
asses adverse drug reactions with anti HIV drugsTimepoint: cross-sectional study(one point). on the day of subject enrollement irrespective of total duration for which patienthas been taking the drug.—

Secondary

MeasureTime frame
assess quality of life of patients with HIV positive and on ARTTimepoint: cross sectional study (one point). irrspective of duration for which patient has taken the drug, patient were assessed for Qol on the day of enrollement itself—

Countries

India

Contacts

Public ContactDr Ruchika Irene Dillu

Rajindra hospital and Goverment Medical College

jsjasbir9@gmail.com8800090326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026